• bitcoinBitcoin(BTC)$63,940.00-0.32%
  • ethereumEthereum(ETH)$1,808.370.57%
  • tetherTether(USDT)$1.000.01%
  • binancecoinBNB(BNB)$592.640.56%
  • usd-coinUSDC(USDC)$1.000.01%
  • rippleXRP(XRP)$0.99-0.24%
  • solanaSolana(SOL)$74.800.46%
  • tronTRON(TRX)$0.3125600.98%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.020.00%
  • HyperliquidHyperliquid(HYPE)$68.740.34%
  • zcashZcash(ZEC)$954.891.94%
  • moneroMonero(XMR)$502.90-0.57%
  • dogecoinDogecoin(DOGE)$0.0595510.49%
  • leo-tokenLEO Token(LEO)$9.340.13%
  • USDSUSDS(USDS)$1.000.01%
  • whitebitWhiteBIT Coin(WBT)$61.970.01%
  • chainlinkChainlink(LINK)$9.220.79%
  • cardanoCardano(ADA)$0.1540510.89%
  • stellarStellar(XLM)$0.138700-1.11%
  • Ethena USDeEthena USDe(USDE)$1.000.03%
  • nearNEAR Protocol(NEAR)$3.401.93%
  • daiDai(DAI)$1.000.02%
  • bitcoin-cashBitcoin Cash(BCH)$209.490.86%
  • litecoinLitecoin(LTC)$44.530.92%
  • CantonCanton(CC)$0.083409-0.16%
  • avalanche-2Avalanche(AVAX)$7.120.41%
  • uniswapUniswap(UNI)$5.220.33%
  • RainRain(RAIN)$0.0044213.23%
  • suiSui(SUI)$0.730.79%
  • tether-goldTether Gold(XAUT)$3,723.46-0.89%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.030.05%
  • USD1USD1(USD1)$1.000.02%
  • Ripple USDRipple USD(RLUSD)$1.000.01%
  • Global DollarGlobal Dollar(USDG)$1.000.00%
  • hedera-hashgraphHedera(HBAR)$0.055839-2.53%
  • paypal-usdPayPal USD(PYUSD)$1.000.01%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.06%
  • BittensorBittensor(TAO)$197.891.48%
  • shiba-inuShiba Inu(SHIB)$0.0000041.18%
  • quant-networkQuant(QNT)$154.49-0.72%
  • crypto-com-chainCronos(CRO)$0.041922-3.43%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • MemeCoreMemeCore(M)$0.88-0.65%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.120.30%
  • okbOKB(OKB)$87.720.89%
  • Falcon USDFalcon USD(USDF)$1.000.03%
  • aaveAave(AAVE)$110.40-0.46%
  • pax-goldPAX Gold(PAXG)$3,722.68-0.93%
  • United StablesUnited Stables(U)$1.000.00%
  • pepePepe(PEPE)$0.0000043.80%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Imagen Raises Over $100M in Growth Capital for Radiologists and AI – Unite.AI

November 19, 2026
in AI & Technology
Reading Time: 2 mins read
A A
Imagen Raises Over 0M in Growth Capital for Radiologists and AI – Unite.AI
ShareShareShareShareShare

Imagen Technologies announced on November 18, 2026, that it had raised more than $100 million in growth capital during 2026 and secured rights to up to 150 million additional imaging studies for AI model training. The funding will support radiologist recruitment and retention alongside investments in clinical resources, operational infrastructure, and technology for its physicians.

YOU MAY ALSO LIKE

Elon Musk Accuses Ukraine Of Being ‘Untruthful’ About Starshield Disruptions

Wilgot Raises $3 Million Seed Round to Improve Product Visibility in AI Shopping – Unite.AI

The capital came from new and existing investors. Imagen reported average year-over-year radiologist headcount growth of approximately 100%, making recruitment a central use of the new funds. The company is pairing that hiring push with AI development intended to improve clinical quality and radiologist efficiency; those improvements are objectives of the investment, not outcomes reported in the announcement.

Imaging Rights Support AI Development

The additional studies span X-ray, CT, MRI, and ultrasound. Imagen plans to use the data access to build and validate models against the diverse, real-world caseloads its radiologists handle. That ties model development directly to its clinical practice, with future systems intended to be trained and assessed against the types of cases its physicians encounter.

Imagen already has an AI development base. Its technology page says its multiple FDA-cleared AI devices were built on a proprietary dataset of more than 200 million imaging studies. The company develops AI in-house and deploys it through its national platform, creating feedback loops across performance, workflow, physician experience, and patient impact. The new rights concern future training and validation; the announcement does not present performance results from models developed with the additional studies.

“The greatest opportunity for AI in radiology isn’t simply to make physicians faster. It’s to give them better tools to deliver exceptional patient care,” said Chief Medical Information Officer Serge Sicular. He said the development goals include improving the quality and consistency of interpretations, streamlining clinical workflows, and giving radiologists more time to focus on cases requiring their expertise.

Recruitment and Clinical Support

The company says it intends to reinvest the benefits of advancing technology into its radiologists and the clinical resources supporting them. Associate Chief Medical Officer Laurence Eckel put the physician-centered model this way: “At Imagen, we’re building the entire practice around the radiologist, from the technology they use to the clinical teams supporting them.”

An August 19, 2026 leadership announcement provides context for that expansion. At the time, Imagen reported services across more than 28 states and more than 2 million imaging studies interpreted annually. It expected its physician team to exceed 200 radiologists by the end of 2026 while expanding partnerships with hospitals, health systems, physician groups, and imaging centers.

Eckel was one of five clinical and operational leaders added in that expansion. His role included helping lead clinical governance, physician development, liaison with the radiologist team, and growth of the national medical practice. The appointments also covered musculoskeletal imaging, interventional radiology, cardiovascular imaging, and operations, adding support around the growing physician group.

The financing and imaging rights give Imagen resources for two connected expansions: a larger radiology practice and a broader base for AI development. Management’s stated model is for technology to support physicians and for the resulting benefits to be reinvested in clinical support. Whether the company can turn those investments into the quality and efficiency gains it is targeting will be central to assessing the growth capital’s impact.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Elon Musk Accuses Ukraine Of Being ‘Untruthful’ About Starshield Disruptions
AI & Technology

Elon Musk Accuses Ukraine Of Being ‘Untruthful’ About Starshield Disruptions

November 19, 2026
Wilgot Raises  Million Seed Round to Improve Product Visibility in AI Shopping – Unite.AI
AI & Technology

Wilgot Raises $3 Million Seed Round to Improve Product Visibility in AI Shopping – Unite.AI

November 19, 2026
Nutrient Data Extraction API: JSON Matching Your Schema With Per-Field Citations and Confidence
AI & Technology

Nutrient Data Extraction API: JSON Matching Your Schema With Per-Field Citations and Confidence

November 19, 2026
Fathom Urges Rapid Implementation of California’s AI Oversight Plan – Unite.AI
AI & Technology

Fathom Urges Rapid Implementation of California’s AI Oversight Plan – Unite.AI

November 19, 2026
Next Post
His Wife Keeps Spending Behind His Back

His Wife Keeps Spending Behind His Back

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
How to Open and Fund a Crypto Account at Schwab

How to Open and Fund a Crypto Account at Schwab

November 14, 2026
Treasury Secretary Scott Bessent says Nvidia should look outside the company for Jensen Huang’s successor

Treasury Secretary Scott Bessent says Nvidia should look outside the company for Jensen Huang’s successor

November 15, 2026
Debbie Shields speaks out on her viral moment riffing with Conan O’Brien

Debbie Shields speaks out on her viral moment riffing with Conan O’Brien

November 18, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!